CAC
CRGX

Cowen and Company’s CARGO Therapeutics CRGX Stock Holding History

Cowen and Company’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-554,305
Closed -$9.1M – 636
2024
Q2 		$9.1M Buy
554,305
+304,305
+122% +$5.79M 0.25% 38
2024
Q1 		$5.58M Buy
+250,000
New +$5.95M 0.22% 47

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cowen and Company's CRGX Position: Q3 2024 in Review

Cowen and Company sold out of CARGO Therapeutics (CRGX) in Q3 2024, closing a stake of 554,305 shares — an estimated $9.1M sold.

Cowen and Company first reported a position in CRGX in Q1 2024 and held it in 2 quarters. The position peaked at $9.1M in Q2 2024. 79 funds tracked by Wall St. Rank hold CRGX as of Q3 2024.

  • Cowen and Company reported no remaining CARGO Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Cowen and Company sold 554,305 CARGO Therapeutics shares in Q3 2024, an estimated $9.1M.
  • Cowen and Company first reported a position in CARGO Therapeutics in Q1 2024 and held it in 2 quarters.
  • Cowen and Company's CARGO Therapeutics position peaked at $9.1M in Q2 2024.
  • 79 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2024.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.